Melissa Tuck - Concepedia

Concepedia

Author

Melissa Tuck

University of Michigan

Also Known As

M Tuck, M. Tuck, M.K. Tuck, Melissa K. Tuck, Melissa Tuck

20

Publications

2.5K

Citations

11

H-Index

24

Concepts

All Affiliations

University of Michigan Michigan Medicine Norwegian Cancer Society Johns Hopkins University

MT

About

Melissa Tuck is an author at University of Michigan specializing in medicine, immunology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	739
2	Health Sciences	2	2	728
3	Immunology	2	2	25
4	Biostatistics	1	1	714
5	Clinical Laboratory Technologies	1	1	714

Melissa Tuck

×

11

Publications

2.5K

Citations

11

H-Index

	Year	Citations
<sup>131</sup>I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma Mark Kaminski, Melissa Tuck, Judith Estes, New England Journal of Medicine	2005	714
Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus Statement <i>Standard Operating Procedure Integration Working Group</i> Melissa Tuck, Daniel W. Chan, David Chia, Journal of Proteome Research Clinical Laboratory TechnologiesClinical EndpointDiagnosisPlasma CollectionTranslational Medicine	2008	714
Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience Mark Kaminski, Judith Estes, Kenneth Zasadny, Blood	2000	521
Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma. Mark Kaminski, Kenneth Zasadny, Isaac R. Francis, Journal of Clinical Oncology	1996	401
Evaluation of Circulating Tumor DNA for Methylated <i>BCAT1</i> and <i>IKZF1</i> to Detect Recurrence of Stage II/Stage III Colorectal Cancer (CRC) Benjamin Musher, Joshua Melson, Gianni Amato, Cancer Epidemiology Biomarkers & Prevention	2020	32
Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience Mark Kaminski, Judith Estes, Kenneth Zasadny, Blood	2000	26
Tositumomab and Iodine I-131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma: Median 10 Year Follow-up Results. Mark Kaminski, Melissa Tuck, Judith Estes, Blood	2009	25
ctDNA transiting into urine is ultrashort and facilitates noninvasive liquid biopsy of HPV+ oropharyngeal cancer Chandan Bhambhani, Qing Kang, Daniel H. Hovelson, JCI Insight	2024	20
Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in <i>BCAT1</i> and <i>IKZF1</i> Susanne K. Pedersen, Benjamin Musher, Lawrence C. LaPointe, Cancer	2022	18
I131-tositumomab monotherapy as frontline treatment for follicular lymphoma: Updated results after a median follow-up of 8 years Mark Kaminski, Judith Estes, Melissa Tuck, Journal of Clinical Oncology ImmunologyPathologyFrontline TreatmentImmunotherapyOncology	2007	14

Page 1